banbao(SH:603398) Zheng Quan Zhi Xing·2025-08-01 16:35Core Viewpoint - Jiangxi Mubang High-tech Co., Ltd. has experienced abnormal stock trading fluctuations, with a cumulative closing price deviation of 12% over three consecutive trading days, leading to regulatory scrutiny and potential delisting risks [1][3]. Group 1: Stock Trading Fluctuations - The company's A-share stock has seen a cumulative closing price deviation of 12% over three consecutive trading days, qualifying as abnormal trading activity according to Shanghai Stock Exchange regulations [1]. - The company has conducted a self-examination and confirmed that there are no undisclosed significant information affecting the stock price, aside from what has already been disclosed [1][5]. Group 2: Financial Performance and Risks - The 2024 annual report revealed a negative net profit, with operating revenue below 300 million yuan after excluding non-core business income, resulting in a delisting risk warning effective May 6, 2025 [1][2]. - The company has received a negative opinion in its internal control audit report for 2024, leading to additional risk warnings [2]. - Legal issues have led to the freezing of bank accounts totaling approximately 27.75 million yuan, including 26.86 million yuan from the fundraising account, which may impact project implementation [2][3]. Group 3: Regulatory Actions - The company has been notified of an investigation by the China Securities Regulatory Commission (CSRC) due to suspected false disclosures in financial reports [3][7]. - As of June 2025, non-operating fund occupation by the controlling shareholder and related parties reached 81.32 million yuan, exceeding 5% of the company's latest audited net assets, which may lead to further regulatory actions if not resolved within one month [2][6]. Group 4: Corporate Governance - The board of directors has confirmed that there are no undisclosed matters that should have been reported according to the Shanghai Stock Exchange regulations, and previous disclosures do not require correction or supplementation [8].